Lv61
2300 积分 2022-07-13 加入
Routes to molecular glue degrader discovery
4天前
已完结
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
12天前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
17天前
已完结
Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography–Tandem Mass Spectrometry
17天前
已完结
Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study
17天前
已完结
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
19天前
已完结
Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
19天前
已完结
Targeted protein degradation: from mechanisms to clinic
19天前
已完结
Methods to accelerate PROTAC drug discovery
19天前
已关闭
Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion
21天前
已完结
皖公网安备34019202002308
